Medical Device News Magazine

Peerbridge Health & Northwell Health Launch Pilot Program to Optimize Treatment for AFib Patients at Lenox Hill Hospital

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Peerbridge Health is collaborating with Northwell Health on their newly launched AFib Center of Excellence, a mutli-displinary effort that optimizes treatment for patients with atrial fibrillation (AFib). With Peerbridge’s support, Northwell’s AFib Center of Excellence will conduct a pilot program focusing on AFib patients with undiagnosed obstructive sleep apnea (OSA).

The pilot aims to help cardiology and sleep physicians better understand the critical link between the two conditions, and how best to quickly and effectively treat AFib and OSA concurrently.

“More than 50% of AFib patients referred for ablation also suffer from undiagnosed sleep apnea, and this remains an underdiagnosed risk factor” said Dr. Nicholas Skipitaris, Western Regional Director of Cardiac Electrophysiology, Northwell Health. “We must address both issues for the best health outcomes. Our pilot program with Peerbridge helps us accomplish this by giving us the best and most accurate data as quickly as possible, and ensuring each patient is properly treated through an individualized approach.”

If left untreated, sleep apnea increases the likelihood of poor health outcomes for this patient population by more than 50 percent, including failed treatments, heart failure, and sudden cardiac death. This contributes to more than $150 billion in healthcare waste each year.

During the pilot, patients will use the Peerbridge Cor™, a multi-channel wireless electrocardiogram (ECG) patch that records every heartbeat while transmitting patient activated events in near-real-time. The Cor is the only wireless ECG patch that can identify and quantify 31 rhythm statements, and accurately assess severity of AFib burden.

“A multi-specialty approach to early diagnosis and treatment of AFib will result in improved health outcomes for our patients,” said Dr. Varinder Singh, Chairman of Cardiovascular Medicine, Lenox Hill Hospital, Northwell Health. “This is especially important for high risk patients – like those with OSA or “master athletes” who compete in endurance events like the New York City Marathon – which we’re seeing more of in our clinical cardiovascular practice.”

Peerbridge is partnering with several sleep industry leaders to address the connection between AFib and OSA, including BetterNight. Peerbridge Health and BetterNight are partnering on a unique new care management solution designed specifically for cardiology practices for earlier identification, treatment, and optimization of ongoing care management of patients with atrial fibrillation (AFib) and obstructive sleep apnea (OSA). The partnership addresses a critical unmet need in the market where there is currently a lack of coordinated care for patients with both AFib and OSA. In addition, this collaboration aims to improve overall patient outcomes and has the potential to save healthcare providers thousands of dollars per patient each year by accelerating diagnosis and treatment of these prevalent conditions.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”